Abnormalities of Reproductive Function in Male Obesity Before and After Bariatric Surgery—A Comprehensive Review

Obesity Surgery

Volumn 25, Issue 7, 2015, Pages 1281-1292

  Rosenblatt, Alberto ^a   Faintuch, Joel ^a   Cecconello, Ivan ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Bariatric surgery; Fecundity; Fertility; Obese males; Reproductive function; Semen; Sexual function

Indexed keywords

ADIPOCYTOKINE; AROMATASE INHIBITOR; GASTROINTESTINAL HORMONE; PHOSPHODIESTERASE V INHIBITOR; SEX HORMONE; TESTOSTERONE;

AGE DISTRIBUTION; BARIATRIC SURGERY; BODY COMPOSITION; BODY FAT DISTRIBUTION; CARDIOVASCULAR DISEASE; DISEASE ASSOCIATION; DYSLIPIDEMIA; ENVIRONMENTAL FACTOR; FERTILITY; FERTILIZATION IN VITRO; HUMAN; HYPERINSULINEMIA; HYPERTENSION; HYPOGONADISM; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; INFERTILITY THERAPY; INSULIN RESISTANCE; INTRACYTOPLASMIC SPERM INJECTION; MALE; MALE INFERTILITY; MORBID OBESITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PENIS ERECTION; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SLEEP DISORDERED BREATHING; SPERM; SPERM QUALITY; WEIGHT REDUCTION; COMPLICATION; ERECTILE DYSFUNCTION; OBESITY, MORBID; SEMEN ANALYSIS; TREATMENT OUTCOME;

BARIATRIC SURGERY; ERECTILE DYSFUNCTION; HUMANS; INFERTILITY, MALE; MALE; OBESITY, MORBID; SEMEN ANALYSIS; TREATMENT OUTCOME;

EID: 84930764896     PISSN: 09608923     EISSN: 17080428     Source Type: Journal    
DOI: 10.1007/s11695-015-1663-1     Document Type: Review

References (148)

1. Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014;384:766–81.
2. Lutz W, O'Neill BC, Scherbov S. Demographics. Europe's population at a turning point. Science. 2003;299:1991–2.
3. Rosenfield A, Schwartz K. Population and development—shifting paradigms, setting goals. N Engl J Med. 2005;352:647–9.
4. Magnusdottir EV, Thorsteinsson T, Thorsteinsdottir S, et al. Persistent organochlorines, sedentary occupation, obesity and human male subfertility. Hum Reprod. 2005;20:208–15.
5. Jensen TK, Andersson AM, Jorgensen N, et al. Body mass index in relation to semen quality and reproductive hormones among 1,558 Danish men. Fertil Steril. 2004;82:863–70.
6. Andersen AG, Jensen TK, Carlsen E, et al. High frequency of sub-optimal semen quality in an unselected population of young men. Hum Reprod. 2000;15:366–72.
7. Morgan SP. Is low fertility a twenty-first-century demographic crisis? Demography. 2003;40:589–603.
8. Duggar E, Bokil M. Population aging will dampen economic growth over the next two decades. In: Moody's Investors Service Moody's, Editor; 2014.
9. Kolotkin RL, Zunker C, Ostbye T. Sexual functioning and obesity: a review. Obesity (Silver Spring). 2012;20:2325–33.
10. Muller M, Grobbee DE, den Tonkelaar I, et al. Endogenous sex hormones and metabolic syndrome in aging men. J Clin Endocrinol Metab. 2005;90:2618–23.
11. Solomon H, Man JW, Jackson G. Erectile dysfunction and the cardiovascular patient: endothelial dysfunction is the common denominator. Heart. 2003;89:251–3.
12. Diaz-Arjonilla M, Schwarcz M, Swerdloff RS, et al. Obesity, low testosterone levels and erectile dysfunction. Int J Impot Res. 2009;21:89–98.
13. Giugliano F, Esposito K, Di Palo C, et al. Erectile dysfunction associates with endothelial dysfunction and raised proinflammatory cytokine levels in obese men. J Endocrinol Investig. 2004;27:665–9.
14. Hotaling JM. Genetics of male infertility. Urol Clin N Am. 2014;41:1–17.
15. Birkeland KI, Hanssen KF, Torjesen PA, et al. Level of sex hormone-binding globulin is positively correlated with insulin sensitivity in men with type 2 diabetes. J Clin Endocrinol Metab. 1993;76:275–8.
16. Pasquali R, Casimirri F, De Iasio R, et al. Insulin regulates testosterone and sex hormone-binding globulin concentrations in adult normal weight and obese men. J Clin Endocrinol Metab. 1995;80:654–8.
17. Pasquali R, Casimirri F, Cantobelli S, et al. Effect of obesity and body fat distribution on sex hormones and insulin in men. Metabolism. 1991;40:101–4.
18. Roth MY, Amory JK, Page ST. Treatment of male infertility secondary to morbid obesity. Nat Clin Pract Endocrinol Metab. 2008;4:415–9.
19. Rebuffe-Scrive M, Marin P, Bjorntorp P. Effect of testosterone on abdominal adipose tissue in men. Int J Obes. 1991;15:791–5.
20. Boden G, Jadali F, White J, et al. Effects of fat on insulin-stimulated carbohydrate metabolism in normal men. J Clin Invest. 1991;88:960–6.
21. Fariello RM, Pariz JR, Spaine DM, et al. Association between obesity and alteration of sperm DNA integrity and mitochondrial activity. BJU Int. 2012;110:863–7.
22. Evenson D, Wixon R. Meta-analysis of sperm DNA fragmentation using the sperm chromatin structure assay. Reprod Biomed Online. 2006;12:466–72.
23. Vermeulen A, Kaufman JM, Deslypere JP, et al. Attenuated luteinizing hormone (LH) pulse amplitude but normal LH pulse frequency, and its relation to plasma androgens in hypogonadism of obese men. J Clin Endocrinol Metab. 1993;76:1140–6.
24. Ryu JW, Kim MS, Kim CH, et al. DHEA administration increases brown fat uncoupling protein 1 levels in obese OLETF rats. Biochem Biophys Res Commun. 2003;303:726–31.
25. Pitteloud N, Mootha VK, Dwyer AA, et al. Relationship between testosterone levels, insulin sensitivity, and mitochondrial function in men. Diabetes Care. 2005;28:1636–42.
26. Edmunds SE, Stubbs AP, Santos AA, et al. Estrogen and androgen regulation of sex hormone binding globulin secretion by a human liver cell line. J Steroid Biochem Mol Biol. 1990;37:733–9.
27. Williams T, Berelowitz M, Joffe SN, et al. Impaired growth hormone responses to growth hormone-releasing factor in obesity. A pituitary defect reversed with weight reduction. N Engl J Med. 1984;311:1403–7.
28. George JT, Millar RP, Anderson RA. Hypothesis: kisspeptin mediates male hypogonadism in obesity and type 2 diabetes. Neuroendocrinology. 2010;91:302–7.
29. Luque RM, Kineman RD, Tena-Sempere M. Regulation of hypothalamic expression of KiSS-1 and GPR54 genes by metabolic factors: analyses using mouse models and a cell line. Endocrinology. 2007;148:4601–11.
30. Jayasena CN, Dhillo WS. Kisspeptin offers a novel therapeutic target in reproduction. Curr Opin Investig Drugs. 2009;10:311–8.
31. George JT, Veldhuis JD, Tena-Sempere M, et al. Exploring the pathophysiology of hypogonadism in men with type 2 diabetes: kisspeptin-10 stimulates serum testosterone and LH secretion in men with type 2 diabetes and mild biochemical hypogonadism. Clin Endocrinol (Oxf). 2013;79:100–4.
32. Esposito K, Giugliano D. The metabolic syndrome and inflammation: association or causation? Nutr Metab Cardiovasc Dis. 2004;14:228–32.
33. Traish AM, Feeley RJ, Guay A. Mechanisms of obesity and related pathologies: androgen deficiency and endothelial dysfunction may be the link between obesity and erectile dysfunction. FEBS J. 2009;276:5755–67.
34. Chung WS, Sohn JH, Park YY. Is obesity an underlying factor in erectile dysfunction? Eur Urol. 1999;36:68–70.
35. Feldman HA, Goldstein I, Hatzichristou DG, et al. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol. 1994;151:54–61.
36. Kaya E, Sikka SC, Gur S. A comprehensive review of metabolic syndrome affecting erectile dysfunction. J Sex Med. 2015. doi:10.1111/jsm.12828.
37. Hammoud A, Gibson M, Hunt SC, et al. Effect of Roux-en-Y gastric bypass surgery on the sex steroids and quality of life in obese men. J Clin Endocrinol Metab. 2009;94:1329–32.
38. Omana JJ, Tamler R, Strohmayer E, et al. Sex hormones levels in men undergoing bariatric surgery. J Am Coll Surg. 2009;209:S22–3.
39. Reis LO, Favaro WJ, Barreiro GC, et al. Erectile dysfunction and hormonal imbalance in morbidly obese male is reversed after gastric bypass surgery: a prospective randomized controlled trial. Int J Androl. 2010;33:736–44.
40. Pauli EM, Legro RS, Demers LM, et al. Diminished paternity and gonadal function with increasing obesity in men. Fertil Steril. 2008;90:346–51.
41. MacDonald AA, Herbison GP, Showell M, et al. The impact of body mass index on semen parameters and reproductive hormones in human males: a systematic review with meta-analysis. Hum Reprod Update. 2010;16:293–311.
42. Aggerholm AS, Thulstrup AM, Toft G, et al. Is overweight a risk factor for reduced semen quality and altered serum sex hormone profile? Fertil Steril. 2008;90:619–26.
43. Duits FH, van Wely M, van der Veen F, et al. Healthy overweight male partners of subfertile couples should not worry about their semen quality. Fertil Steril. 2010;94:1356–9.
44. Relwani R, Berger D, Santoro N, et al. Semen parameters are unrelated to BMI but vary with SSRI use and prior urological surgery. Reprod Sci. 2011;18:391–7.
45. Lotti F, Corona G, Colpi GM, et al. Elevated body mass index correlates with higher seminal plasma interleukin 8 levels and ultrasonographic abnormalities of the prostate in men attending an andrology clinic for infertility. J Endocrinol Investig. 2011;34:e336–42.
46. Eskandar M, Al-Asmari M, Babu Chaduvula S, et al. Impact of male obesity on semen quality and serum sex hormones. Adv Urol. 2012;2012:407601.
47. Hammoud AO, Wilde N, Gibson M, et al. Male obesity and alteration in sperm parameters. Fertil Steril. 2008;90:2222–5.
48. Kort HI, Massey JB, Elsner CW, et al. Impact of body mass index values on sperm quantity and quality. J Androl. 2006;27:450–2.
49. Chavarro JE, Toth TL, Wright DL, et al. Body mass index in relation to semen quality, sperm DNA integrity, and serum reproductive hormone levels among men attending an infertility clinic. Fertil Steril. 2010;93:2222–31.
50. Ramlau-Hansen CH, Thulstrup AM, Nohr EA, et al. Subfecundity in overweight and obese couples. Hum Reprod. 2007;22:1634–7.
51. Hajshafiha M, Ghareaghaji R, Salemi S, et al. Association of body mass index with some fertility markers among male partners of infertile couples. Int J Gen Med. 2013;6:447–51.
52. Koloszar S, Fejes I, Zavaczki Z, et al. Effect of body weight on sperm concentration in normozoospermic males. Arch Androl. 2005;51:299–304.
53. Sermondade N, Faure C, Fezeu L, et al. BMI in relation to sperm count: an updated systematic review and collaborative meta-analysis. Hum Reprod Update. 2013;19:221–31.
54. Hofny ER, Ali ME, Abdel-Hafez HZ, et al. Semen parameters and hormonal profile in obese fertile and infertile males. Fertil Steril. 2010;94:581–4.
55. Sekhavat L, Moein MR. The effect of male body mass index on sperm parameters. Aging Male. 2010;13:155–8.
56. Fejes I, Koloszar S, Zavaczki Z, et al. Effect of body weight on testosterone/estradiol ratio in oligozoospermic patients. Arch Androl. 2006;52:97–102.
57. Hammiche F, Laven JS, Twigt JM, et al. Body mass index and central adiposity are associated with sperm quality in men of subfertile couples. Hum Reprod. 2012;27:2365–72.
58. Shayeb AG, Harrild K, Mathers E, et al. An exploration of the association between male body mass index and semen quality. Reprod Biomed Online. 2011;23:717–23.
59. Nguyen RH, Wilcox AJ, Skjaerven R, et al. Men's body mass index and infertility. Hum Reprod. 2007;22:2488–93.
60. Ohwaki K, Endo F, Yano E. Relationship between body mass index and infertility in healthy male Japanese workers: a pilot study. Andrologia. 2009;41:100–4.
61. Sallmen M, Sandler DP, Hoppin JA, et al. Reduced fertility among overweight and obese men. Epidemiology. 2006;17:520–3.
62. Hanafy S, Halawa FA, Mostafa T, et al. Serum leptin correlates in infertile oligozoospermic males. Andrologia. 2007;39:177–80.
63. Eisenberg ML, Kim S, Chen Z, et al. The relationship between male BMI and waist circumference on semen quality: data from the LIFE study. Hum Reprod. 2014;29:193–200.
64. Stewart TM, Liu DY, Garrett C, et al. Associations between andrological measures, hormones and semen quality in fertile Australian men: inverse relationship between obesity and sperm output. Hum Reprod. 2009;24:1561–8.
65. Keltz J, Zapantis A, Jindal SK, et al. Overweight men: clinical pregnancy after ART is decreased in IVF but not in ICSI cycles. J Assist Reprod Genet. 2010;27:539–44.
66. Merhi ZO, Keltz J, Zapantis A, et al. Male adiposity impairs clinical pregnancy rate by in vitro fertilization without affecting day 3 embryo quality. Obesity (Silver Spring). 2013;21:1608–12.
67. Braga DP, Halpern G, Figueira Rde C, et al. Food intake and social habits in male patients and its relationship to intracytoplasmic sperm injection outcomes. Fertil Steril. 2012;97:53–9.
68. Martini AC, Tissera A, Estofan D, et al. Overweight and seminal quality: a study of 794 patients. Fertil Steril. 2010;94:1739–43.
69. Klaus S. Adipose tissue as a regulator of energy balance. Curr Drug Targets. 2004;5:241–50.
70. Warren MP, Perlroth NE. The effects of intense exercise on the female reproductive system. J Endocrinol. 2001;170:3–11.
71. Linna MS, Raevuori A, Haukka J, et al. Reproductive health outcomes in eating disorders. Int J Eat Disord. 2013;46:826–33.
72. Leisegang K, Bouic PJ, Menkveld R, et al. Obesity is associated with increased seminal insulin and leptin alongside reduced fertility parameters in a controlled male cohort. Reprod Biol Endocrinol. 2014;12:34.
73. Machtinger R, Combelles CM, Missmer SA, et al. The association between severe obesity and characteristics of failed fertilized oocytes. Hum Reprod. 2012;27:3198–207.
74. Sermondade N, Faure C, Fezeu L, et al. Obesity and increased risk for oligozoospermia and azoospermia. Arch Intern Med. 2012;172:440–2.
75. Kotani K, Tokunaga K, Fujioka S, et al. Sexual dimorphism of age-related changes in whole-body fat distribution in the obese. Int J Obes Relat Metab Disord. 1994;18:207–12.
76. Pasquali R. Obesity and androgens: facts and perspectives. Fertil Steril. 2006;85:1319–40.
77. Marin P, Andersson B, Ottosson M, et al. The morphology and metabolism of intraabdominal adipose tissue in men. Metabolism. 1992;41:1242–8.
78. Garcia-Cruz E, Piqueras M, Gosalbez D, et al. Erectile dysfunction and its severity are related to the number of cardiovascular risk factors. Actas Urol Esp. 2010;36:291–5.
79. Ahmed I, Goldstein BJ. Cardiovascular risk in the spectrum of type 2 diabetes mellitus. Mt Sinai J Med. 2006;73:759–68.
80. Haque WA, Garg A. Adipocyte biology and adipocytokines. Clin Lab Med. 2004;24:217–34.
81. Bigornia SJ, Farb MG, Mott MM, et al. Relation of depot-specific adipose inflammation to insulin resistance in human obesity. Nutr Diabetes. 2012;2:e30.
82. Moschos S, Chan JL, Mantzoros CS. Leptin and reproduction: a review. Fertil Steril. 2002;77:433–44.
83. Jope T, Lammert A, Kratzsch J, et al. Leptin and leptin receptor in human seminal plasma and in human spermatozoa. Int J Androl. 2003;26:335–41.
84. Isidori AM, Caprio M, Strollo F, et al. Leptin and androgens in male obesity: evidence for leptin contribution to reduced androgen levels. J Clin Endocrinol Metab. 1999;84:3673–80.
85. Scherer PE, Williams S, Fogliano M, et al. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem. 1995;270:26746–9.
86. Hoffstedt J, Arvidsson E, Sjolin E, et al. Adipose tissue adiponectin production and adiponectin serum concentration in human obesity and insulin resistance. J Clin Endocrinol Metab. 2004;89:1391–6.
87. Bai J, Liu Y, Niu GF, et al. Relationship between adiponectin and testosterone in patients with type 2 diabetes. Biochem Med (Zagreb). 2011;21:65–70.
88. Kratzsch J, Paasch U, Grunewald S, et al. Resistin correlates with elastase and interleukin-6 in human seminal plasma. Reprod Biomed Online. 2008;16:283–8.
89. Patrikakos P, Toutouzas KG, Gazouli M, et al. Long-term plasma ghrelin and leptin modulation after sleeve gastrectomy in Wistar rats in comparison with gastric tissue ghrelin expression. Obes Surg. 2011;21:1432–7.
90. Arvat E, Di Vito L, Broglio F, et al. Preliminary evidence that Ghrelin, the natural GH secretagogue (GHS)-receptor ligand, strongly stimulates GH secretion in humans. J Endocrinol Investig. 2000;23:493–5.
91. Lasselin J, Magne E, Beau C, et al. Adipose inflammation in obesity: relationship with circulating levels of inflammatory markers and association with surgery-induced weight loss. J Clin Endocrinol Metab. 2014;99:E53–61.
92. Mesarwi O, Polak J, Jun J, et al. Sleep disorders and the development of insulin resistance and obesity. Endocrinol Metab Clin N Am. 2013;42:617–34.
93. Nannapaneni S, Ramar K, Surani S. Effect of obstructive sleep apnea on type 2 diabetes mellitus: a comprehensive literature review. World J Diabetes. 2013;4:238–44.
94. Gaytan F, Barreiro ML, Chopin LK, et al. Immunolocalization of ghrelin and its functional receptor, the type 1a growth hormone secretagogue receptor, in the cyclic human ovary. J Clin Endocrinol Metab. 2003;88:879–87.
95. Tena-Sempere M, Barreiro ML. Leptin in male reproduction: the testis paradigm. Mol Cell Endocrinol. 2002;188:9–13.
96. Luboshitzky R, Aviv A, Hefetz A, et al. Decreased pituitary-gonadal secretion in men with obstructive sleep apnea. J Clin Endocrinol Metab. 2002;87:3394–8.
97. Marinelli D, Gaspari L, Pedotti P, et al. Mini-review of studies on the effect of smoking and drinking habits on semen parameters. Int J Hyg Environ Health. 2004;207:185–92.
98. Fronczak CM, Kim ED, Barqawi AB. The insults of illicit drug use on male fertility. J Androl. 2012;33:515–28.
99. Pant N, Pant AB, Chaturvedi PK, et al. Semen quality of environmentally exposed human population: the toxicological consequence. Environ Sci Pollut Res Int. 2013;20:8274–81.
100. Hauser R, Altshul L, Chen Z, et al. Environmental organochlorines and semen quality: results of a pilot study. Environ Health Perspect. 2002;110:229–33.
101. Gumbs AA, Modlin IM, Ballantyne GH. Changes in insulin resistance following bariatric surgery: role of caloric restriction and weight loss. Obes Surg. 2005;15:462–73.
102. Petelin A, Bizjak M, Cernelic-Bizjak M, et al. Low-grade inflammation in overweight and obese adults is affected by weight loss program. J Endocrinol Invest. 2014;37:745–55
103. Kadera BE, Lum K, Grant J, et al. Remission of type 2 diabetes after Roux-en-Y gastric bypass is associated with greater weight loss. Surg Obes Relat Dis. 2009;5:305–9.
104. Fava C, Montagnana M, Favaloro EJ, et al. Obstructive sleep apnea syndrome and cardiovascular diseases. Semin Thromb Hemost. 2011;37:280–97.
105. Hammoud AO, Walker JM, Gibson M, et al. Sleep apnea, reproductive hormones and quality of sexual life in severely obese men. Obesity (Silver Spring). 2011;19:1118–23.
106. Budweiser S, Enderlein S, Jorres RA, et al. Sleep apnea is an independent correlate of erectile and sexual dysfunction. J Sex Med. 2009;6:3147–57.
107. Grunstein RR, Handelsman DJ, Lawrence SJ, et al. Neuroendocrine dysfunction in sleep apnea: reversal by continuous positive airways pressure therapy. J Clin Endocrinol Metab. 1989;68:352–8.
108. Luboshitzky R, Lavie L, Shen-Orr Z, et al. Altered luteinizing hormone and testosterone secretion in middle-aged obese men with obstructive sleep apnea. Obes Res. 2005;13:780–6.
109. Macrea MM, Martin TJ, Zagrean L. Infertility and obstructive sleep apnea: the effect of continuous positive airway pressure therapy on serum prolactin levels. Sleep Breath. 2010;14:253–7.
110. Slutsky M, Levin JL, Levy BS. Azoospermia and oligospermia among a large cohort of DBCP applicators in 12 countries. Int J Occup Environ Health. 1999;5:116–22.
111. Jensen TK, Heitmann BL, Jensen MB, et al. High dietary intake of saturated fat is associated with reduced semen quality among 701 young Danish men from the general population. Am J Clin Nutr. 2013;97:411–8.
112. Attaman JA, Toth TL, Furtado J, et al. Dietary fat and semen quality among men attending a fertility clinic. Hum Reprod. 2012;27:1466–74.
113. Palmer NO, Bakos HW, Fullston T, et al. Impact of obesity on male fertility, sperm function and molecular composition. Spermatogenesis. 2012;2:253–63.
114. Thonneau P, Bujan L, Multigner L, et al. Occupational heat exposure and male fertility: a review. Hum Reprod. 1998;13:2122–5.
115. Shafik A, Olfat S. Lipectomy in the treatment of scrotal lipomatosis. Br J Urol. 1981;53:55–61.
116. Ghanayem BI, Bai R, Kissling GE, et al. Diet-induced obesity in male mice is associated with reduced fertility and potentiation of acrylamide-induced reproductive toxicity. Biol Reprod. 2010;82:96–104.
117. Aitken RJ, Clarkson JS, Fishel S. Generation of reactive oxygen species, lipid peroxidation, and human sperm function. Biol Reprod. 1989;41:183–97.
118. Le Lay S, Simard G, Martinez MC, et al. Oxidative stress and metabolic pathologies: from an adipocentric point of view. Oxidative Med Cell Longev. 2014;2014:908539.
119. Furukawa S, Fujita T, Shimabukuro M, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest. 2004;114:1752–61.
120. Mack SR, Everingham J, Zaneveld LJ. Isolation and partial characterization of the plasma membrane from human spermatozoa. J Exp Zool. 1986;240:127–36.
121. Cross NL. Role of cholesterol in sperm capacitation. Biol Reprod. 1998;59:7–11.
122. Ollero M, Powers RD, Alvarez JG. Variation of docosahexaenoic acid content in subsets of human spermatozoa at different stages of maturation: implications for sperm lipoperoxidative damage. Mol Reprod Dev. 2000;55:326–34.
123. Dandona P, Aljada A, Chaudhuri A, et al. Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation. 2005;111:1448–54.
124. Tunc O, Bakos HW, Tremellen K. Impact of body mass index on seminal oxidative stress. Andrologia. 2011;43:121–8.
125. Dusing R. Sexual dysfunction in male patients with hypertension: influence of antihypertensive drugs. Drugs. 2005;65:773–86.
126. Rosen RC, Marin H. Prevalence of antidepressant-associated erectile dysfunction. J Clin Psychiatry. 2003;64 Suppl 10:5–10.
127. Peuskens J, Sienaert P, De Hert M. Sexual dysfunction: the unspoken side effect of antipsychotics. Eur Psychiatry. 1998;13:23s–30.
128. Levy BR, Pilver CE. Residual stigma: psychological distress among the formerly overweight. Soc Sci Med. 2012;75:297–9.
129. Marin P, Holmang S, Gustafsson C, et al. Androgen treatment of abdominally obese men. Obes Res. 1993;1:245–51.
130. Saad F, Gooren L, Haider A, et al. Effects of testosterone gel followed by parenteral testosterone undecanoate on sexual dysfunction and on features of the metabolic syndrome. Andrologia. 2008;40:44–8.
131. Xu L, Freeman G, Cowling BJ, et al. Testosterone therapy and cardiovascular events among men: a systematic review and meta-analysis of placebo-controlled randomized trials. BMC Med. 2013;11:108.
132. Stokes VJ, Anderson RA, George JT. How does obesity affect fertility in men - and what are the treatment options? Clin Endocrinol (Oxf). 2014. doi:10.1111/cen.12591.
133. Zumoff B, Miller LK, Strain GW. Reversal of the hypogonadotropic hypogonadism of obese men by administration of the aromatase inhibitor testolactone. Metabolism. 2003;52:1126–8.
134. Du Plessis SS, Cabler S, McAlister DA, et al. The effect of obesity on sperm disorders and male infertility. Nat Rev Urol. 2010;7:153–61.
135. Li Z, Wang L, Cai J, et al. Correlation of sperm DNA damage with IVF and ICSI outcomes: a systematic review and meta-analysis. J Assist Reprod Genet. 2006;23:367–76.
136. Orvieto R, Meltcer S, Nahum R, et al. The influence of body mass index on in vitro fertilization outcome. Int J Gynaecol Obstet. 2009;104:53–5.
137. Rittenberg V, Seshadri S, Sunkara SK, et al. Effect of body mass index on IVF treatment outcome: an updated systematic review and meta-analysis. Reprod Biomed Online. 2011;23:421–39.
138. Sneed ML, Uhler ML, Grotjan HE, et al. Body mass index: impact on IVF success appears age-related. Hum Reprod. 2008;23:1835–9.
139. Zhang D, Zhu Y, Gao H, et al. Overweight and obesity negatively affect the outcomes of ovarian stimulation and in vitro fertilisation: a cohort study of 2628 Chinese women. Gynecol Endocrinol. 2010;26:325–32.
140. Martinuzzi K, Ryan S, Luna M, et al. Elevated body mass index (BMI) does not adversely affect in vitro fertilization outcome in young women. J Assist Reprod Genet. 2008;25:169–75.
141. Rosenblatt A, Faintuch J, Cecconello I. Sexual hormones and erectile function more than 6 years after bariatric surgery. Surg Obes Relat Dis. 2013;9:636–40.
142. Corona G, Rastrelli G, Monami M, et al. Body weight loss reverts obesity-associated hypogonadotropic hypogonadism: a systematic review and meta-analysis. Eur J Endocrinol. 2013;168:829–43.
143. Calderon B, Galdon A, Calanas A, et al. Effects of bariatric surgery on male obesity-associated secondary hypogonadism: comparison of laparoscopic gastric bypass with restrictive procedures. Obes Surg. 2014;24:1686–92.
144. Samavat J, Facchiano E, Lucchese M, et al. Hypogonadism as an additional indication for bariatric surgery in male morbid obesity? Eur J Endocrinol. 2014;171:555–60.
145. Reis LO, Zani EL, Saad RD, et al. Bariatric surgery does not interfere with sperm quality—a preliminary long-term study. Reprod Sci. 2012;19:1057–62.
146. di Frega AS, Dale B, Di Matteo L, et al. Secondary male factor infertility after Roux-en-Y gastric bypass for morbid obesity: case report. Hum Reprod. 2005;20:997–8.
147. Sermondade N, Massin N, Boitrelle F, et al. Sperm parameters and male fertility after bariatric surgery: three case series. Reprod Biomed Online. 2012;24:206–10.
148. Lazaros L, Hatzi E, Markoula S, et al. Dramatic reduction in sperm parameters following bariatric surgery: report of two cases. Andrologia. 2012;44:428–32.